LOS ANGELES, April 19, 2018 -- With April being Alcohol Awareness Month, studies show 83% of people who drink excessively received no advice or encouragement from family and friends to cut down their drinking. Women with drinking problems were much less likely than men to receive advice with only 11.7% of them encouraged to seek help.
Using alcohol is socially acceptable and often even encouraged, despite the very real risks of substance abuse and health issues. According to a study published in JAMA Psychiatry, a staggering 1 in 8 Americans struggle with alcohol abuse.
“Hearing from friends or family that they might need help with alcohol is one of the main factors in people seeking treatment. And the sooner they get help, the sooner they can go on with their lives with a healthier relationship with alcohol,” says Dr. Diane Rothon, Medical Director for alcohol recovery program Alavida Health.
Only 10% of addicts ever get treatment
“The key to helping Americans with alcohol use disorder lies in having open and honest conversations about alcohol, helping people identify they have a problem, and finding them the right type of help to treat their addiction,” Dr. Rothon says.
Once someone has identified that they need help, finding the right kind of treatment is the next step. There are plenty of options, from traditional 12-step programs like AA to more revolutionary treatments such as Alavida Health, a science-based treatment program that promotes controlled drinking therapy instead of abstinence and touts a 75% success rate.
About Alavida
Alavida Health is a science-based treatment program that combines non-addictive medication, behavioral therapy and technology to help people decrease or stop their consumption of alcohol. Alavida clients work with their doctor and therapist for typically four to six months and can access their doctors in person or virtually, making the access barrier-free. Available in North America since 2016, Alavida currently has offices in Canada and the USA. The treatment model has a success rate of over 75 percent, in line with a clinical study and 20 years of ongoing practice conducted in Finland. More information about Alavida and how treatment works can be found at www.alavida.co.
Contact:
Binu Koshy
Media Relations
P: 905-617-1988 / 1-888-315-8550
E: [email protected]
Christine Gomes
Marketing Manager
E: [email protected]


Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says
Capital One Says AML Review Led to Closure of Trump Organization Accounts
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel
Same sparkle, different story: how lab-grown diamonds are transforming the market
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger 



